Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “CONTRACEPTIVE DEVICES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11Linked to original sources
PubMed1982

Intrauterine contraceptive devices in diabetic women.

11 of 30 (36.6%) insulin-dependent diabetic women fitted with intrauterine contraceptive devices (IUCDs) became pregnant within 1 year, whereas the pregnancy rate for non-diabetic women fitted with the same types of IUCD by the same consultant gynaecologists over a similar time period was 4 per 100 women years (4%). As soon as the high risk was recognised, devices were removed (2 from diabetic women who were pregnant and 19 from non-pregnant diabetic women), and patients were advised about other methods of contraception. The IUCDs were examined in a scanning electron microscope with X-ray microprobe analysis to measure the amount of copper eroded from the wire, the extent of the encrustation (if any) deposited on the wire, and the composition of the deposit, and the data were compared with those for 111 devices removed from non-diabetic women, 40% of the IUCDs from diabetic women had sulphur and chloride in the deposit, compared with 15.3% of IUCDs from normal women, and fewer IUCDs from diabetic women had calcareous deposits. In devices from normal women, erosion and deposition seemed to occur independently, but in IUCDs from diabetic women, there was high erosion, there were also large deposits, and where there was little deposit, the erosion was slight. 7 of 14 IUCDs taken from normal women who had become pregnant with an IUCD in situ had a high sulphur plus chloride deposit; none of these IUCDs had a predominantly calcareous deposit compared with 19.8% of the IUCDs from non-pregnant normal women. The evidence militates against the insertion of IUCDs in diabetic patients and indicated that, even in non-diabetic women, there may be small groups for whom the risk of becoming pregnant is very high.

Adult↗
PubMed1975

Perforation of the uterus by the copper-t and copper-7 intrauterine contraceptive devices.

Uterine perforation in patients wearing the Copper-T and the Copper-7 intrauterine contraceptive devices has been studied. In Bollnäs, Sweden, three perforations occurred in 1 156 insertions of the Copper-7, and in New York, USA, six perforations occurred in 1 153 insertions of the Copper-T. Cervical perforation seems to be a special feature of the Copper-T, while the Copper-7 tends to perforate through the uterine wall. The perforations can be divided into "primary" perforations, related to the insertion procedure, and "secondary" perforations, caused by uterine contractions. The diagnosis and treatment of uterine perforations by intrauterine devices is discussed.

Adult↗
PubMed1982

Prevalence of cervical neoplasia and infection in women using intrauterine contraceptive devices.

Consecutive cervical smears examined in 1980 were divided into those from women using intrauterine contraceptive devices (IUDs) (757) and those not using them (11,711). Actinomycetes were not found in the non-IUD group but were present in 7.0% of the IUD group and were significantly more common in women with plastic IUDs (11.7%) than in those with copper ones (2.1%). Cervical intraepithelial neoplasia (CIN), grade 3, was significantly more common in the IUD group (1.06%) than in the non-IUD group (0.34%). Trichomonas infection was significantly more common in women with IUDs and actinomycetes (9.4%), in those with IUDs and without actinomycetes (1.6%) and in those without IUDs attending the clinic for sexually transmitted disease (STD) (5.9%) than in non-IUD, non-STD women (0.7%). Candida infection was not more common in women with IUDs (with or without actinomycetes) (1.2%) than in non-IUD, non-STD women (2.1%) but was significantly more common in STD women (3.8%). A repeat study in 1981 showed a similar prevalence of CIN 3: 1.03% of the IUD group (485) and 0.33% of the non-IUD group (10,850).

Actinomycetales Infections↗
PubMed1983

Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.

Twenty-one women with intrauterine contraceptive devices (IUCD) and severe dysmenorrhea were studied. All the women who participated in the study had primary dysmenorrhea of varying intensities. The insertion of IUCD increased the intensity of dysmenorrheic pain. The effect of naproxen (Naprosyn) on pain alleviation was studied in a double-blind cross-over trial using naproxen and placebo. The effect of naproxen was significantly better than that of placebo (P less than 0.01). No severe side effects occurred during the treatment. There was no difference in the duration and amount of the menstrual blood flow during naproxen treatment compared to placebo according to the women's own judgement.

Adult↗
PubMed1976

Plasminogen activators in the endometrium of women using intrauterine contraceptive devices.

Plasminogen activators in the endometrium before and after the insertion of an intrauterine contraceptive device (IUCD) were studied; an increase in the concentration was found following IUCD insertion in 16 of the 20 women. This change will enhance endometrial fibrinolysis and may explain the increased menstrual bleeding which usually follows insertion of an IUCD.

Adult↗
PubMed1984

Unusual displacement of an intra-uterine contraceptive device. A case report.

Since its introduction in 1959 the plastic intra-uterine contraceptive device (IUCD) has been accepted as a safe and convenient means of preventing conception. Nevertheless, use of the IUCD has been attended by complications, notably perforation of the uterus by the device. An unusual case of translocation of an IUCD--the device was located within the lumen of the appendix--is presented.

Adult↗
PubMed1976

Incidence of infections associated with the intrauterine contraceptive device in an isolated community.

In an attempt to estimate more precisely the frequency of infections associated with the intrauterine contraceptive device (IUD), all gynecologic morbidity resulting from infection and occurring during a two-year period in an isolated community was reviewed. Ten septic abortions occurred, and all but one were associated with IUD use. In 26 gynecologic inpatients (41 per cent of all admissions for acute pelvic inflammatory disease), pelvic infection was associated with IUD use. In contradistinction to the septic abortion data, implicating only the Dalkon Shield, the gynecologic infections were associated with various types of devices.

Abortion, Septic↗
PubMed1976

Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.

Increased menstrual loss and irregular uterine bleeding are major drawbacks to acceptibility of intrauterine contraceptive devices (IUCDs). Fibrinolytic activity around IUCDs removed from 80 women was measured by embedding the device immediately after removal in a plasminogen-rich fibrin plate. In fifteen of the women an endometrial biopsy was also taken at the time of removal of the IUCD. In women who had the IUCDs removed because of bleeding a much higher fibrinolytic activity was found than in women not complaining of excessive bleeding. The fibrinolytic activity was shown to be due to plasminogen activator and not plasmin. The findings suggest that the excessive menstrual bleeding which occurs with the IUCD may be due to enhancement of fibrinolytic activity in the endometrium which can be modified by fibrinolytic inhibitors such as epsilon aminocaproic acid.

Aminocaproic Acid↗
PubMed1975

Actinomycosis infections associated with intrauterine contraceptive devices.

A series of 10 instances of genital actinomycosis infection complicating the use of intrauterine contraceptive devices is recorded and its pathogenesis described. The likelihood is suggested that this complication is more frequent than is generally appreciated. A pathway of infection extending upward from the patient's anus, across the perineum, and up the vagina and cervix is suggested as the route of infection. The traumatizing effect of the device and a previously existing or intercurrent infection as additional contributing factors to the development of actinomycotic infection in the female genitalia is also postulated.

Abscess↗
PubMedDate not supplied

[Use of the contraceptive device, Intragal, after induced abortion].

Undesirable effects were investigated in 116 women with the intrauterine contraceptive device Intragal inserted after artificial abortion. A total of 2351 exposed cycles were analysed. There were, per 1000 exposed cycles, 3.1 pregnancies, 6.6 spontaneous expulsions, and 4.1 device removals because of bleeding. No inflammation process requiring device removal was recorded.

Abortion, Induced↗
PubMed1984

Intrauterine contraceptive device localization by clinical evaluation and real-time ultrasonography.

A total of 43 Intrauterine Contraceptive Device (IUD) wearers were examined clinically and ultrasonically in order to ascertain the intrauterine position of IUDs (copper devices of five different types). The time elapsed from the insertion was 2-26 months. The mean age of the women was 28 years; 95% of them were parous. The intrauterine location of the IUD was assessed clinically by means of threads cut to a standard length. In the ultrasound examination, the distance of the uppermost point of the stem of the device from the fundal wall was measured within an accuracy of 1 mm. The clinical assessment of the IUD location was found to agree surprisingly closely with the results of the ultrasound examination. The clinical assessment deviated significantly from the ultrasonography findings in about 10% of the cases.

Adult↗
PubMed1987

Intrauterine contraceptive devices: MR imaging.

To assess the safety of magnetic resonance (MR) imaging in women who have an intrauterine contraceptive device (IUD) in place, in vitro and in vivo studies were performed at both 0.35 and 1.5 T. Two commonly used IUDs were tested, one all of plastic, the other with a coil of copper wire on it. Specifically, the study assessed possible motion of the IUD in the magnetic field, potential of the IUD to heat up during two spin-echo imaging sequences commonly used in MR imaging of the pelvis (2,000/30 and 60 [repetition time, msec/echo time, msec], and 500/30), and the appearance on MR images of the IUD devices. A retrospective review of MR images of the pelvis in six women who had an IUD in place was also performed. Results show that an IUD does not move under the influence of the magnetic field, does not heat during spin-echo sequences commonly used for pelvic imaging, and does not produce artifacts in vitro or in vivo. Patients with either type of IUD can be safely imaged with MR, and MR images of the pelvis are not degraded by the presence of an IUD.

Female↗